Anorexia nervosa could be a hybrid ‘metabo-psychiatric disorder’ according to a global study that could help to understand why some individuals with anorexia nervosa drop back to dangerously low weights, even after hospital-based refeeding.
Published in Nature Genetics, the large-scale genome-wide association study led by researchers at King’s and University of North Carolina at Chapel Hill was undertaken by over 100 academics worldwide and identified eight genetic variants linked to anorexia nervosa. The results suggest that the genetic origins of the disorder are both metabolic and psychiatric.
Anorexia nervosa is a serious and potentially life-threatening illness. Symptoms of anorexia can include a dangerously low body weight, an intense fear of gaining weight, and a distorted body image. Anorexia nervosa affects between 1-2% of women and 0.2-0.4% of men and has the highest mortality rate of any psychiatric illness.
The researchers combined data collected by the Anorexia Nervosa Genetics Initiative and the Eating Disorders Working Group of the Psychiatric Genomics Consortium. The resulting dataset included 16,992 cases of anorexia nervosa and 55,525 controls, from 17 countries across North America, Europe, and Australasia.
The key findings of the study are:
- The genetic basis of anorexia nervosa overlaps with metabolic (including glycaemic), lipid (fats), and anthropometric (body measurement) traits, and the study shows that this is independent of genetic effects that influence body mass index (BMI).
- The genetic basis of anorexia nervosa overlaps with other psychiatric disorders such as obsessive-compulsive disorder, depression, anxiety, and schizophrenia.
- Genetic factors associated with anorexia nervosa also influence physical activity, which could explain the tendency for people with anorexia nervosa to be highly active.
Co-lead author of the study Dr Gerome Breen, from the National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre and the Institute of Psychiatry, Psychology & Neuroscience at King’s said: “Metabolic abnormalities seen in patients with anorexia nervosa are most often attributed to starvation, but our study shows metabolic differences may also contribute to the development of the disorder. Furthermore, our analyses indicate that the metabolic factors may play nearly or just as strong a role as purely psychiatric effects.”
Professor Janet Treasure, also from the Institute of Psychiatry, Psychology & Neuroscience, said: “Over time there has been uncertainty about the framing of anorexia nervosa because of the mixture of physical and psychiatric features. Our results confirm this duality and suggest that integrating metabolic information may help clinicians to develop better ways to treat eating disorders.”
The study concludes that anorexia nervosa may need to be thought of as a hybrid ‘metabo-psychiatric disorder’ and that it will be important to consider both metabolic and psychological risks factors when exploring new avenues for treating this potentially lethal illness.
Andrew Radford, Chief Executive of Beat, the eating disorder charity, said: "This is ground-breaking research that significantly increases our understanding of the genetic origins of this serious illness. We strongly encourage researchers to examine the results of this study and consider how it can contribute to the development of new treatments so we can end the pain and suffering of eating disorders."
Dr Breen and colleagues are launching a major new research study in September 2019 to recruit people who have experienced anorexia, bulimia or binge-eating disorder in order to better understand the genetic and environmental links and help develop better treatments.